TY - JOUR
T1 - Review article
T2 - biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction
AU - Wang, Xiao Jing
AU - Camilleri, Michael
AU - Vanner, Stephen
AU - Tuck, Caroline
N1 - Funding Information:
CT was supported by a joint Fellowship from Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism and Diabetes (INMD), the Canadian Nutrition Society and Nestle Health Sciences (funding reference number CNU‐158242); as well as the CIHR IMAGINE Strategy for Patient‐Oriented Research (SPOR). MC was supported by the National Institutes of Health of the United States (RO1 DK115950).
Publisher Copyright:
© 2019 John Wiley & Sons Ltd
PY - 2019
Y1 - 2019
N2 - Background: Due to the paucity of targeted therapy for irritable bowel syndrome (IBS), many patients turn to dietary modifications for symptom management. The combination of five subgroups of poorly absorbed and rapidly fermented carbohydrates—fructans, galacto-oligosaccharides, lactose, excess fructose and polyols—are thought to trigger gastrointestinal symptoms and are referred to collectively as “FODMAPs”. Aims: To examine the biological plausibility and mechanisms by which foods high in specific FODMAP subgroups cause symptoms, and to use this information to explore the possibility of targeting select dietary components to allow for a more personalised approach to dietary adjustment. Methods: Recent literature was analysed via search databases including Medline, PubMed and Scopus. Results: Lactose, fructans and galacto-oligosaccharides have strong biologic plausibility for symptom generation due to lack of hydrolases resulting in distention from osmosis and rapid fermentation. However, excess fructose and polyols may only cause symptoms in specific individuals when consumed in high doses, but this remains to be established. There is evidence to suggest that certain patient characteristics such as ethnicity may predict response to lactose, but differentiation of other subgroups is difficult prior to dietary manipulation. Conclusions: While some clear mechanisms of action for symptom generation have been established, further research is needed to understand which patients will respond to specific FODMAP subgroup restriction. We suggest that clinicians consider in some patients a tailored, personalised “bottom-up” approach to the low-FODMAP diet, such as dietary restriction relevant to the patients’ ethnicity, symptom profile and usual dietary intake.
AB - Background: Due to the paucity of targeted therapy for irritable bowel syndrome (IBS), many patients turn to dietary modifications for symptom management. The combination of five subgroups of poorly absorbed and rapidly fermented carbohydrates—fructans, galacto-oligosaccharides, lactose, excess fructose and polyols—are thought to trigger gastrointestinal symptoms and are referred to collectively as “FODMAPs”. Aims: To examine the biological plausibility and mechanisms by which foods high in specific FODMAP subgroups cause symptoms, and to use this information to explore the possibility of targeting select dietary components to allow for a more personalised approach to dietary adjustment. Methods: Recent literature was analysed via search databases including Medline, PubMed and Scopus. Results: Lactose, fructans and galacto-oligosaccharides have strong biologic plausibility for symptom generation due to lack of hydrolases resulting in distention from osmosis and rapid fermentation. However, excess fructose and polyols may only cause symptoms in specific individuals when consumed in high doses, but this remains to be established. There is evidence to suggest that certain patient characteristics such as ethnicity may predict response to lactose, but differentiation of other subgroups is difficult prior to dietary manipulation. Conclusions: While some clear mechanisms of action for symptom generation have been established, further research is needed to understand which patients will respond to specific FODMAP subgroup restriction. We suggest that clinicians consider in some patients a tailored, personalised “bottom-up” approach to the low-FODMAP diet, such as dietary restriction relevant to the patients’ ethnicity, symptom profile and usual dietary intake.
UR - http://www.scopus.com/inward/record.url?scp=85069880698&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069880698&partnerID=8YFLogxK
U2 - 10.1111/apt.15419
DO - 10.1111/apt.15419
M3 - Review article
C2 - 31309595
AN - SCOPUS:85069880698
SN - 0269-2813
VL - 50
SP - 517
EP - 529
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
IS - 5
ER -